Szemészet, 2001 (138. évfolyam, 1-4. szám)

2001-06-01 / 2. szám

Szemészet

Irodalom

1. Albert D.M., Todes-Taylor N., Wagoner M., Nordlund J.J., Lerner A.B.: Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol; 118, 34-36 (1982).

2. Albert D.M., Searl S.S., Forget B., Lavin P.T., Kirkwood J., Nordlund J.J.: Uveal findings in patients with cutaneous melanoma. Am J Ophthalmol 95, 474-479 (1983).

3. Albert D.M., Chang M.A., Lamping K., Weiter J., Sober A.: The dysplastic nevus syndrome. A pedigree with primary malignant melanomas of the choroid and skin. Ophthalmology 92, 1728-1734 (1985).

4. Albert L.S., Rhodes A.R., Sober A. 71: Dysplastic nevi and cutaneous melanoma: markers for increased risk for affected persons and blood relatives. J Am Acad Dermatol 22, 69-75 (1990).

5. Char D.H., Jerome L, McCoy J.L., Herberman R.B.: Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma. Am J Ophthalmol 79, 812-816 (1975).

6. Fournier G.A., Albert D.M., Wagoner M.D.: Choroidal halo nevus occurring in a patient with vitiligo. Surv Ophthalmol 28, 671-672 (1984).

7. Hammer H., Oláh J., Tóth-Molnár E.: Dysplastic nevi are a risk factor for uveal melanoma. Eur J Ophthalmol 6, 472-474 (1994).

8. Hammer H., Tóth-Molnár E., Oláh J., DobozyA.: Cutaneous dysplastic naevi: risk factor for uveal melanoma. Lancet 346, 255- 256 (letter). (1995).

9. van Hees C.L.M., de Boer A., Jager M.J., Bleeker J.C., Kemme //., Bergman W.: Are atypical nevi a risk factor for uveal melanoma? A case control study. J Invest Derm 103, 202-205 (1994).

10. McCarthy J.M., Rootman J., Horsman D., White V.A.: Conjunctival and uveal melanoma in the dysplastic nevus syndrome. Surv Ophthalmol 37, 377-386 (1993).

11. Nordlund J.J., Kirkwood J., Forget B.M., Scheibner A., Albert D.M., Lerner E., Milton G.W.: Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 45, 1855-1861 (1985).

12. Rigel D.S., Rivers J.K., Kopf A.W., Friedman R.J., Vinokur A.F., Heilman E.R., Levenstein M.: Dysplastic nevi. Markers for increased risk for melanoma. Cancer 63, 386-389 (1989).

13. Rodriquez-Sains R.S.: Ocular findings in patients with dysplastic nevus syndrome. Ophthalmology 93, 661-665 (1986).

14. Shields J.A.: Diagnosis and management of intraocular tumors. St. Louis, CV Mosby, 1983.

15. Singh A.D., Shields C.L., Shields J.A., Eagle R.C., De Potter P: Uveal melanoma and familial atypical multiple mole and melanoma syndrome (FAMMM). Ophthal Genet 16, 53-61 (1995).

16. Skolnick M.: In: Cairns J., Lyon J.L., Skolnick M. (eds.): Cancer incidence in defined populations. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory 285-297 (1980).

17. Tóth-Molnár E., Hammer H., Oláh J.: Cutaneous dysplastic nevi in uveal melanoma patients: markers for prognosis? Melanoma Research 10, 36-39 (2000).

18. Tóth-Molnár E., Hammer H., Oláh J.: Dysplasticus naevus: az uvea melanoma prognózisának markere? Szemészet 136, 253-256 (1999).

19. Zimmerman L.E.: Melanocytes, melanocytic nevi and melanocytomas. Invest Ophthalmol 4, 11-41 (1965).

A szerző levelezési címe: Dr. Tóth-Molnár Edit Szegedi Tudományegyetem, Szemészeti Klinika 6720 Szeged, Korányi fasor 10-11.

Tóth-Molnár Edit